Dynasore, a dynamin inhibitor, induces PAI-1 expression in MeT-5A human pleural mesothelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 40, Issue 6, 2009, Pages 692-700

  Chung, Chi Li ^a   Sheu, Joen Rong ^a   Liu, Hsiang Erh ^a   Chang, Shi Chuan ^b   Chou, Yung Chen ^a   Chen, Wei Lin ^b   Chou, Duen Suey ^a   Hsiao, George ^a,c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Dynasore; JNK; MMP 2; PAI 1; TGF 1

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CHLORPROMAZINE; DYNAMIN; DYNAMIN INHIBITOR; DYNASORE; GELATINASE A; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLEURODESING AGENT; PROTEIN INHIBITOR; PROTEIN KINASE INHIBITOR; SMAD2 PROTEIN; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MESOTHELIUM CELL; NUCLEOTIDE SEQUENCE; PLASMINOGEN ACTIVATION; PLEURA; PLEURAL FIBROSIS; PLEURODESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

CELL LINE; DYNAMINS; ENDOCYTOSIS; EPITHELIUM; GENE EXPRESSION REGULATION; HUMANS; HYDRAZONES; MAP KINASE KINASE 4; MATRIX METALLOPROTEINASE 2; MODELS, BIOLOGICAL; OXIDATIVE STRESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLEURA; RNA, MESSENGER; TETRAZOLIUM SALTS; THIAZOLES; TRANSFORMING GROWTH FACTOR BETA1;

EID: 66349085317     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2008-0087OC     Document Type: Article

References (53)

1. Idell S, Zwieb C, Boggaram J, Holiday D, Johnson AR, Raghu G. Mechanisms of fibrin formation and lysis by human lung fibroblasts: influence of TGF-β and TNF-α. Am J Physiol 1992;263:L487-L494.
2. Huggins JT, Sahn SA. Causes and management of pleural fibrosis. Respirology 2004;9:441-447. (Pubitemid 40179748)
3. Idell S, Zwieb C, Kumar A, Koenig KB, Johnson AR. Pathways of fibrin turnover of human pleural mesothelial cells in vitro. Am J Respir Cell Mol Biol 1992;7:414-426.
4. Dennler S, Itoh S, Vivien D, ten Dijke P, Huet S, Gauthier JM. Direct binding of Smad3 and Smad4 to critical TGF-β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J 1998;17:3091-3100.
5. Woodward RN, Finn AV, Dichek DA. Identification of intracellular pathways through which TGF-β1 upregulates PAI-1 expression in endothelial cells. Atherosclerosis 2006;186:92-100.
6. Vayalil PK, Iles KE, Choi J, Yi AK, Postlethwait EM, Liu RM. Glutathione suppresses TGF-β-induced PAI-1 expression by inhibiting p38 and JNK MAPK and the binding of AP-1, SP-1, and Smad to the PAI-1 promoter. Am J Physiol Lung Cell Mol Physiol 2007;293:L1281-L1292. (Pubitemid 350159412)
7. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL. Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 2003;5:410-421. (Pubitemid 36592263)
8. Chen CL, Liu IH, Fliesler SJ, Han X, Huang SS, Huang JS. Cholesterol suppresses cellular TGF-beta responsiveness: implications in atherogenesis. J Cell Sci 2007;120:3509-3521. (Pubitemid 350120944)
9. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T. Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 2006;10:839-850. (Pubitemid 43779110)
10. Zastrow MV, Sorkin A. Signaling on the endocytic pathway. Curr Opin Cell Biol 2007;19:436-445. (Pubitemid 47287673)
11. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 1983;65:55-63. (Pubitemid 14203433)
12. Hsiao G, Huang HY, Fong TH, Shen MY, Lin CH, Teng CM, Sheu JR. Inhibitory mechanisms of YC-1 and PMC in the induction of iNOS expression by lipoteichoic acid in RAW 264.7 macrophages. Biochem Pharmacol 2004;67:1411-1419. (Pubitemid 38315106)
13. Zhang Y, McCluskey K, Fujii K, Wahl LM. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNFalpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J Immunol 1998;161:3071-3076. (Pubitemid 28425734)
14. Dona M, Dell'Aica I, Pezzato E, Sartor L, Calabrese F, Della Barbera M, Donella-Deana A, Appendino G, Borsarini A, Caniato R, et al. Hyperforin inhibits cancer invasion and metastasis. Cancer Res 2004;64:6225-6232. (Pubitemid 39129424)
15. Derynck R. Zhang YE. Smad-dependent and Smad-independent pathways in TGF-β family signaling. Nature 2003;425:577-584.
16. Whawell SA, Thompson JN. Cytokine-induce release of plasminogen activator inhibitor-1 by human mesothelial cells. Eur J Surg 1995;161:315-317.
17. Agrenius V, Chmielewska J, Widstrom O, Blomback M. Pleural fibrinolytic activity is decreased in inflammation as demonstrated in quinacrine pleurodesis treatment of malignant pleural effusion. Am Rev Respir Dis 1989;140:1381-1385. (Pubitemid 19276227)
18. Liu RM. Oxidative stress, plasminogen activator inhibitor 1, and lung fibrosis. Antioxid Redox Signal 2008;10:303-319.
19. Penheiter SG, Mitchell H, Garamszegi N, Edens M, Doré JJ Jr, Leof EB. Internalization-dependent and -independent requirements for transforming growth factor-β receptor signaling via the Smad pathway. Mol Cell Biol 2002;22:4750-4759. (Pubitemid 34620410)
20. Hayes S, Chawla A, Corvera S. TGF-b receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J Cell Biol 2002;158:1239-1249.
21. Runyan CE, Schnaper HW, Poncelet AC. The role of internalization in TGF-β1-induced Smad2 association with SARA and Smad2-dependent signaling in human mesangial cells. J Biol Chem 2005;280:8300-8308.
22. Newton AJ, Kirchhausen T, Murthy VN. Inhibition of dynamin completely blocks compensatory synaptic vesicle endocytosis. Proc Natl Acad Sci USA 2006;103:17955-17960. (Pubitemid 44852267)
23. Nagano Y, Mavrakis KJ, Lee KL, Fujii T, Koinuma D, Sase H, Yuki K, Isogaya K, Saitoh M, Imamura T, et al. Arkadia induces degradation of SnoN and c-Ski to enhance transforming growth factor-beta signaling. J Biol Chem 2007;282:20492-20501. (Pubitemid 47100041)
24. Mavrakis KJ, Andrew RL, Lee KL, Petropoulou C, Dixon JE, Navaratnam N, Norris DP, Episkopou V. Arkadia enhances Nodal/ TGF-beta signaling by coupling phospho-Smad2/3 activity and turnover. PLoS Biol 2007;5:e67. (Pubitemid 46422976)
25. Zhong J, Gencay MM, Bubendorf L, Burgess JK, Parson H, Robinson BW, Tamm M, Black JL, Roth M. ERK1/2 and p38 MAP kinase control MMP-2, MT1-MMP, and TIMP action and affect cell migration: a comparison between mesothelioma and mesothelial cells. J Cell Physiol 2006;207:540-552.
26. Onichtchouk D, Chen YG, Dosch R, Gawantka V, Delius H, Massague J, Niehrs C. Silencing of TGF-beta signaling by the pseudoreceptor BAMBI. Nature 1999;401:480-485. (Pubitemid 29470206)
27. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, Schwabe RF. TLR4 enhances TGF-β signaling and hepatic fibrosis. Nat Med 2007;13:1324-1332. (Pubitemid 350073596)
28. Pannu J, Nakerakanti S, Smith E, ten Dijke P, Trojanowska M. Transforming growth factor-β receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathway. J Biol Chem 2007;282:10405-10413. (Pubitemid 47093454)
29. Henley JR, Krueger EW, Oswald BJ, McNiven MA. Dynamin-mediated internalization of caveolae. J Cell Biol 1998;14:85-99. (Pubitemid 28182643)
30. Abazeed ME, Blanchette JM, Fuller RS. Cell-free transport from the trans-golgi network to late endosome requires factors involved in formation and consumption of clathrin-coated vesicles. J Biol Chem 2005;280:4442-4450. (Pubitemid 40288609)
31. Ito T, Williams JD, Fraser DJ, Phillips AO. Hyaluronan regulates transforming growth factor-β1 receptor compartmentalization. J Biol Chem 2004;279:25326-25332. (Pubitemid 38756787)
32. Zhang XL, Topley N, Ito T, Phillips A. Interleukin-6 regulation of transforming growth factor (TGF)-β receptor compartmentalization and turnover enhances TGF-β1 signaling. J Biol Chem 2005;280:12239-12245. (Pubitemid 40491035)
33. 1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am J Physiol Lung Cell Mol Physiol 2007;293:L790-L799.
34. Engel ME, McDonnell MA, Law BK, Moses HL. Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J Biol Chem 1999;274:37413-37420.
35. Funaba M, Zimmerman CM, Mathews LS. Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase. J Biol Chem 2002;277:41361-41368. (Pubitemid 35257436)
36. Kamaraju AK, Roberts AB. Role of Rho/ROCK and p38 MAP kinase pathways in transforming growth factor-mediated Smad-dependent growth inhibition of human breast carcinoma cells in vivo. J Biol Chem 2005;280:1024-1036.
37. Bakin AV, Tomlinson AK, Bhowmick NA, Moses HL, Arteaga CL. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem 2000;275:36803-36810. (Pubitemid 32002090)
38. Runyan CE, Schnaper HW, Poncelet AC. The phosphatidylinositol 3-kinase/Akt pathway enhances Smad3-stimulated mesangial cell collagen I expression in response to transforming growth factor-β1. J Biol Chem 2004;279:2632-2639. (Pubitemid 38114250)
39. Keeton MR, Curriden SA, van Zonneveld AJ, Loskutoff DJ. Identification of regulatory sequences in the type 1 plasminogen activator inhibitor gene responsive to transforming growth factor beta. J Biol Chem 1991;266:23048-23052. (Pubitemid 21908758)
40. Swiatkowska M, Szemraj J, Cierniewski CS. Induction of PAI-1 expression by tumor necrosis factor in endothelial cells is mediated by its responsive element located in the 4G/5G site. FEBS J 2005;272:5821-5831. (Pubitemid 41689354)
41. Javelaud D, Mauviel A. Crosstalk mechanisms between the mitogeniactivated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene 2005;24:5742-5750. (Pubitemid 43086134)
42. Pontrelli P, Ranieri E, Ursi M, Ghosh-Choudhury G, Gesualdo L, Schena FP, Grandaliano G. jun-N-terminal kinase regulates thrombin- induced PAI-1 gene expression in proximal tubular epithelial cells. Kidney Int 2004;65:2249-2261. (Pubitemid 38670011)
43. 2- terminal kinase in G-protein-coupled receptor agonist-induced cardiac plasminogen activator inhibitor-1 expression. J Mol Cell Cardiol 2005;38:583-592.
44. Vulin AI, Stanley FM. Oxidative stress activates the plasminogen activator inhibitor type 1 (PAI-1) promoter through an AP-1 response element and cooperates with insulin for additive effects on PAI-1 transcription. J Biol Chem 2004;279:25172-25178. (Pubitemid 38756767)
45. Arndt PG, Young SK, Worthen GS. Regulation of lipopolysaccharide-induced lung inflammation by plasminogen activator inhibitor-1 through a JNK-mediated pathway. J Biol Chem 2005;175:4049-4059. (Pubitemid 41292068)
46. Yao D, Ehrlich M, Henis YI, Leof EB. Transforming growth factor-beta receptors interact with AP2 by direct binding to beta 2 subunit. Mol Biol Cell 2002;13:4001-4012. (Pubitemid 35398566)
47. Hamaguchi E, Takamura T, Shimizu A, Nagai Y. Tumor necrosis factor-alpha and troglitazone regulate plasminogen activator inhibitor type 1 production through extracellular signal-regulated kinase- and nuclear factor-kappaB- dependent pathways in cultured human umbilical vein endothelial cells. J Pharmacol Exp Ther 2003;307:987-994. (Pubitemid 37494216)
48. Uchiyama T, Kurabayashi M, Ohyama Y, Utsugi T, Akuzawa N, Sato M, Tomono S, Kawazu S, Nagai R. Hypoxia induces transcription of the plasminogen activator inhibitor-1 gene through genistein-sensitive tyrosine kinase pathways in vascular endothelial cells. Arterioscler Thromb Vasc Biol 2000;20:1155-1161. (Pubitemid 30207596)
49. Kobayashi N, Nakano S, Mita SI, Kobayashi T, Honda T, Tsubokou Y, Matsuoka H. Involvement of Rho-kinase pathway for angiotensin IIinduced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats. J Pharmacol Exp Ther 2002;301:459-466. (Pubitemid 34429955)
50. Rega G, Kaun C, Weiss TW, Demyanets S, Zorn G, Kastl SP, Steiner S, Seidinger D, Kopp CW, Frey M, et al. Inflammatory cytokines interleukin-6 and oncostatin M induce plasminogen activator inhibitor-1 in human adipose tissue. Circulation 2005;111:1938-1945. (Pubitemid 40570213)
51. Acencio MM, Vargas FS, Marchi E, Carnevale GG, Teixeira LR, Antonangelo L, Broaddus VC. Pleural mesothelial cells mediate inflammatory and profibrotic responses in talc-induced pleurodesis. Lung 2007;185:343-348. (Pubitemid 350165560)
52. Lee YC, Lane KB, Parker RE, Ayo DS, Rogers JT, Diters RW, Thompson PJ, Light RW. Transforming growth factor-β2 (TGF-β2) produces effective pleurodesis in sheep with no systemic complications. Thorax 2000;55:1058-1062.
53. Light RW, Cheng DS, Lee YC, Rogers J, Davidson J, Lane KB. A single intrapleural injection of transforming growth factor-β2 produces an excellent pleurodesis in rabbits. Am J Respir Crit Care Med 2000;162:98-104. (Pubitemid 30469805)